Cited by 487Barrier Structure and Function StudiesAdvanced Drug Delivery SystemsNerve injury and regeneration

The DOI matches its Crossref record; 310 of the 310 references it cites were found in a registry or an index.

Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations

Thorne, Robert G., Frey, William H.·2001·Clinical Pharmacokinetics

DOI 10.2165/00003088-200140120-00003

Open this paper in CoChat — free account

Abstract

Neurotrophic factors are proteins with considerable potential in the treatment of central nervous system (CNS) diseases and traumatic injuries. However, a significant challenge to their clinical use is the difficulty associated with delivering these proteins to the CNS. Neurotrophic factors are hydrophilic, typically basic, monomeric or dimeric proteins, mostly in the size range of 5 to 30 kDa. Neurotrophic factors potently support the development, growth and survival of neurons, eliciting biological effects at concentrations in the nanomolar to femtomolar range. They are not orally bioavailable and the blood-brain and blood-cerebrospinal fluid barriers severely limit their ability to enter into and act on sites in the CNS following parenteral systemic routes of administration. Most neurotrophic factors have short in vivo half-lives and poor pharmacokinetic profiles. Their access to the CNS is restricted by rapid enzymatic inactivation, multiple clearance processes, potential immunogenicity and sequestration by binding proteins and other components of the blood and peripheral tissues. The development of targeted drug delivery strategies for neurotrophic factors will probably determine their clinical effectiveness for CNS conditions. Achieving significant CNS target site concentrations while limiting systemic exposure and distribution to peripheral sites of action will lessen unwanted pleiotropic effects and toxicity. Local introduction of neurotrophic factors into the CNS intraparenchymally by direct injection/infusion or by implantation of delivery vectors such as polymer matrices or genetically modified cells yields the highest degree of targeting, but is limited by diffusion restrictions and invasiveness. Delivery of neurotrophic factors into the cerebrospinal fluid (CSF) following intracerebroventricular or intrathecal administration is less invasive and allows access to a much wider area of the CNS through CSF circulation pathways. However, diffusional and cellular barriers to penetration into surrounding CNS tissue and significant clearance of CSF into the venous and lymphatic circulation are also limiting. Unconventional delivery strategies such as intranasal administration may offer some degree of CNS targeting with minimal invasiveness. This review presents a summary of the neurotrophic factors and their indications for CNS disorders, their physicochemical characteristics and the different approaches that have been attempted or suggested for their delivery to the CNS. Future directions for further research such as the potential for CNS disease treatment utilising combinations of neurotrophic factors, displacement strategies, small molecule mimetics, chimaeric molecules and gene therapy are also discussed.

Integrity signals

Registry

Crossref · 10.2165/00003088-200140120-00003

Cites

310 of 310 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
The Nerve Growth Factor 35 Years Later
Levi‐Montalcini, R. (1987) · Science · doi:10.1126/science.3306916 · Cited by 3,109
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Heldin, C., & Westermark, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1283 · Cited by 2,521
Random Walks in Biology
Berg, H. C. (1984) · Princeton University Press eBooks · doi:10.1515/9780691279886 · Cited by 2,417
Proteomics to study genes and genomes
Pandey, A., & Mann, M. (2000) · Nature · doi:10.1038/35015709 · Cited by 2,399
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Drug Delivery and Targeting
Hillery, A. M., Lloyd, A. W., & Swarbrick, J. (2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Physiology of the Neurotrophins
Lewin, G. R., & Barde, Y. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.001445 · Cited by 1,959
The Basic Science of Gene Therapy
Mulligan, R. C. (1993) · Science · doi:10.1126/science.8493530 · Cited by 1,741
Gene therapy - promises, problems and prospects
Verma, I. M., & Somia, N. (1997) · Nature · doi:10.1038/38410 · Cited by 1,681
The Sequence of the Human Genome
Venter, J. C., Smith, H. O., & Adams, M. D. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.237016 · Cited by 1,665
The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.
Rinderknecht, E., & HUMBEL, R. E. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40889-1 · Cited by 1,545
Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections
Hefti, F. F. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02155.1986 · Cited by 1,445
Basic Neurochemistry: Molecular, Cellular, and Medical Aspects
Siegel, G. J., & Agranoff, B. W. (1989) · Cited by 1,359
Transport of brain-derived neurotrophic factor across the blood–brain barrier
Pan, W., Banks, W. A., Fasold, M. B., Bluth, J., & Kastin, A. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00141-5 · Cited by 1,354
Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease
Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J. L., Chen, E., Palfi, S., Roitberg, B. Z., et al. (2000) · Science · doi:10.1126/science.290.5492.767 · Cited by 1,251
TRANSPLANTATION OF EMBRYONIC DOPAMINE NEURONS FOR SEVERE PARKINSON'S DISEASE
Reed, R., Reene, P. A. E. G., Reeze, R. O. E. B., Ei, W., Ouchel, W. I. D. U. M., Ao, R. I. K., Infield, W., Ulver, S. H. C., Rojanowski, J. O. Q. T., Idelberg, D. A. E., et al. (2001) · Cited by 1,001
PLATELET-DERIVED GROWTH FACTOR
Ross, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92760-8 · Cited by 952
Textbook of Biochemistry with Clinical Correlations
(1983) · Biochemical Education · doi:10.1016/0307-4412(83)90121-8 · Cited by 918
Extracellular space structure revealed by diffusion analysis
Nicholson, C., & Syková, E. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01261-2 · Cited by 914
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Peripheral Infusion of IGF-I Selectively Induces Neurogenesis in the Adult Rat Hippocampus
Åberg, M. A. I., Åberg, N. D., Hedbäcker, H., Oscarsson, J., & Eriksson, P. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02896.2000 · Cited by 852
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00067-1 · Cited by 847
Neurogenesis in the adult brain: death of a dogma
Gross, C. G. (2000) · Nature reviews. Neuroscience · doi:10.1038/35036235 · Cited by 840
trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor
Squinto, S. P., Stitt, T. N., Aldrich, T. H., Davis, S. H., Blanco, S. M., Radziejewski, C. H., Glass, D. J., Masiakowski, P., Furth, M. E., Valenzuela, D. M., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90395-f · Cited by 838
TGFβ Signaling: Receptors, Transducers, and Mad Proteins
Massagué, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81296-9 · Cited by 836
Role of morphogenetic proteins in skeletal tissue engineering and regeneration
Reddi, A. H. (1998) · Nature Biotechnology · doi:10.1038/nbt0398-247 · Cited by 831
The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor
Soppet, D., Escandon, E., Maragos, J., Middlemas, D. S., Raid, S. W., Blair, J., Burton, L. E., Stanton, B. R., Kaplan, D. R., Hunter, T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90396-g · Cited by 820
A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences
Martı́n-Zanca, D., Hughes, S. H., & Barbacid, M. (1986) · Nature · doi:10.1038/319743a0 · Cited by 812
Growth factors in the extracellular matrix.
Taipale, J., & Keski‐Oja, J. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034166 · Cited by 759
Evidence for a ‘Paravascular’ fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space
Rennels, M. L., Gregory, T. F., Blaumanis, O. R., Fujimoto, K., & Grady, P. A. (1985) · Brain Research · doi:10.1016/0006-8993(85)91383-6 · Cited by 752
Spinal Cord Repair in Adult Paraplegic Rats: Partial Restoration of Hind Limb Function
Cheng, H., Cao, Y., & Olson, L. (1996) · Science · doi:10.1126/science.273.5274.510 · Cited by 743
Neurturin, a relative of glial-cell-line-derived neurotrophic factor
Kotzbauer, P. T., Lampe, P. A., Heuckeroth, R. O., Golden, J. P., Creedon, D. J., Johnson Jr, E. M., & Milbrandt, J. (1996) · Nature · doi:10.1038/384467a0 · Cited by 710
Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section
Sendtner, M., Holtmann, B., Kolbeck, R., Thoenen, H., & Barde, Y. (1992) · Nature · doi:10.1038/360757a0 · Cited by 706
Rat Transforming Growth Factor Type 1: Structure and Relation to Epidermal Growth Factor
Marquardt, H., Hunkapiller, M. W., Hood, L., & Todaro, G. J. (1984) · Science · doi:10.1126/science.6320373 · Cited by 657
Cellular Delivery of Neurotrophin-3 Promotes Corticospinal Axonal Growth and Partial Functional Recovery after Spinal Cord Injury
Grill, R., Murai, K. K., Blesch, A., Gage, F. H., & Tuszynski, M. H. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05560.1997 · Cited by 619
Methods in Neurosciences
Conn, P. M. (1992) · Methods in neurosciences · doi:10.1016/b978-0-12-185269-6.50005-9 · Cited by 616
Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.
Knüsel, B., Winslow, J. W., Rosenthal, A., Burton, L. E., Seid, D. P., Nikolics, K., & Hefti, F. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.961 · Cited by 601
Artemin, a Novel Member of the GDNF Ligand Family, Supports Peripheral and Central Neurons and Signals through the GFRα3–RET Receptor Complex
Baloh, R. H., Tansey, M. G., Lampe, P. A., Fahrner, T. J., Enomoto, H., Simburger, K. S., Leitner, M. L., Araki, T., Johnson, E. M., & Milbrandt, J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80649-2 · Cited by 588
Purification of human platelet-derived growth factor.
Antoniades, H. N., Scher, C. D., & Stiles, C. D. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.4.1809 · Cited by 583
Physiology of the CSF and Blood-Brain Barriers
Davson, H., & Segal, M. B. (1996) · Medical Entomology and Zoology · Cited by 582
Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines
Arakawa, Y., Sendtner, M., & Thoenen, H. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-11-03507.1990 · Cited by 578
The Primary Structure of Epidermal Growth Factor
Savage, C. R., Inagami, T., & Cohen, S. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44569-9 · Cited by 539
A NERVE GROWTH-STIMULATING FACTOR ISOLATED FROM SARCOM AS 37 AND 180
Cohen, S., Levi‐Montalcini, R., & Hamburger, V. (1954) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.40.10.1014 · Cited by 530
Region-Specific Neurotrophin Imbalances in Alzheimer Disease: Decreased Levels of Brain-Derived Neurotrophic Factor and Increased Levels of Nerve Growth Factor in Hippocampus and Cortical Areas
Hock, C., Heese, K., Hulette, C., Rosenberg, C., & Otten, U. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.846 · Cited by 523
The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3
Cordon‐Cardo, C., Tapley, P. M., Jing, S., Nanduri, V., O’Rourke, E. C., Lamballe, F., Kovary, K., Klein, R., Jones, K. R., Reichardt, L. F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90149-s · Cited by 522
Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II
Knüsel, B., Michel, P. P., Schwaber, J. S., & Hefti, F. F. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-02-00558.1990 · Cited by 521
CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance
Kida, S., Pantazis, A., & Weller, R. O. (1993) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1993.tb00476.x · Cited by 520
Persephin, a Novel Neurotrophic Factor Related to GDNF and Neurturin
Milbrandt, J., de Sauvage, F. J., Fahrner, T. J., Baloh, R. H., Leitner, M. L., Tansey, M. G., Lampe, P. A., Heuckeroth, R. O., Kotzbauer, P. T., Simburger, K. S., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80453-5 · Cited by 494
Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease
Jönhagen, M. E., Nordberg, A. K., Amberla, K., Bäckman, L., Ebendal, T., Meyerson, B. A., Olson, L., Seiger, Å., Shigeta, M., Theodorsson, E., et al. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017069 · Cited by 472
Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).
Prentis, R., Lis, Y., & Walker, Sr. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03318.x · Cited by 471
Improving protein therapeutics with sustained-release formulations
Putney, S. D., & Burke, P. A. (1998) · Nature Biotechnology · doi:10.1038/nbt0298-153 · Cited by 469
CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport
Pardridge, W. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051781.x · Cited by 460
Platelet-derived growth factor. I. High yield purification and evidence for multiple forms.
Raines, E. W., & Ross, R. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34649-0 · Cited by 456
Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia
Sharkey, J., & Butcher, S. P. (1994) · Nature · doi:10.1038/371336a0 · Cited by 455
Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients
Aebischer, P., Schluep, M., Déglon, N., Joseph, J., Hirt, L., Heyd, B., Goddard, M. B., Hammang, J. P., Zurn, A. D., Kato, A. C., et al. (1996) · Nature Medicine · doi:10.1038/nm0696-696 · Cited by 446
Cardiotrophin-1
Pennica, D., Shaw, K. J., Swanson, T. A., Moore, M. W., Shelton, D. L., Zioncheck, K., Rosenthal, A., Taga, T., Paoni, N. F., & Wood, W. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10915 · Cited by 435
Neurotrophin-6 is a new member of the nerve growth factor family
Götz, R., Köster, R. W., Winkler, C., Raulf, F., Lottspeich, F., Schartl, M., & Thoenen, H. (1994) · Nature · doi:10.1038/372266a0 · Cited by 410
A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis
ALS CNTF Treatment Study Group (1996) · Neurology · doi:10.1212/wnl.46.5.1244 · Cited by 405
The effect of systemically administered recombinant human nerve growth factor in healthy human subjects
Petty, B. G., Cornblath, D. R., Adornato, B. T., Chaudhry, V., Flexner, C. W., Wachsman, M., Sinicropi, D. V., Burton, L. E., & Peroutka, S. J. (1994) · Annals of Neurology · doi:10.1002/ana.410360221 · Cited by 402
Trophic effects of purines in neurons and glial cells
Rathbone, M. P., Middlemiss, P. J., Gysbers, J. W., Andrew, C. M., Herman, M. A. R., Reed, J. K., Ciccarelli, R., Iorio, P. D., & Caciagli, F. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00017-9 · Cited by 398
Insulin-like growth factors cross the blood-brain barrier
Reinhardt, R., & Bondy, C. A. (1994) · Endocrinology · doi:10.1210/endo.135.5.7525251 · Cited by 390
A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury
Gluckman, P. D., Klempt, N. D., Guan, J., Mallard, C. E., Sirimanne, E. S., Dragunow, M., Klempt, M., Singh, K., Williams, C., & Nikolics, K. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91774-k · Cited by 384
Neurotrophic Factors Increase Axonal Growth after Spinal Cord Injury and Transplantation in the Adult Rat
Bregman, B. S., McAtee, M., Dai, H., & Kuhn, P. L. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6705 · Cited by 377
Macromolecular permeability across the blood-nerve and blood-brain barriers.
Poduslo, J. F., Curran, G. L., & Berg, C. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5705 · Cited by 377
Stimulation of Neonatal and Adult Brain Neurogenesis by Subcutaneous Injection of Basic Fibroblast Growth Factor
Wagner, J. P., Black, I. B., & DiCicco-Bloom, E. M. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-14-06006.1999 · Cited by 374
Quantitative analysis of the olfactory pathway for drug delivery to the brain
Thorne, R. G., Emory, C. R., Ala, T. A., & Frey, W. H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00637-6 · Cited by 352
Self-citation
The Intracerebral Movement of Proteins Injected into Blood and Cerebrospinal Fluid of Mice
Brightman, M. (1968) · Progress in brain research · doi:10.1016/s0079-6123(08)64147-3 · Cited by 351
Human platelet-derived growth factor. Purification and resolution into two active protein fractions.
Deuel, T. F., Huang, J. S., Proffitt, R. T., et al. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52482-6 · Cited by 350
Physiology and Pathophysiology of the Cerebrospinal Fluid
Davson, H., Welch, K., & Segal, M. B. (1987) · Medical Entomology and Zoology · Cited by 347
Treatment of the Chronically Injured Spinal Cord with Neurotrophic Factors Can Promote Axonal Regeneration from Supraspinal Neurons
Ye, J.-H., & Houlé, J. D. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6353 · Cited by 345
Volume transmission in the CNS and its relevance for neuropsychopharmacology
Zoli, M. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01343-7 · Cited by 344
Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.
Kupfer, S. R., Underwood, L. E., Baxter, R. C., & Clemmons, D. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116212 · Cited by 335
Identification of Type I and Type II Serine/Threonine Kinase Receptors for Growth/Differentiation Factor-5
Nishitoh, H., Ichijo, H., Kimura, M., Matsumoto, T., Makishima, F., Yamaguchi, A., Yamashita, H., ENOMOTO, S., & Miyazono, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21345 · Cited by 329
Drug Delivery to the Brain
Pardridge, W. M. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199707000-00001 · Cited by 329
Blood-Brain Barrier Penetration and in Vivo Activity of an NGF Conjugate
Friden, P. M., Walus, L. R., Watson, P. M., Doctrow, S. R., Kozarich, J. W., Bäckman, C. M., Bergman, H., Hoffer, B. J., Bloom, F. E., & Granholm, A. (1993) · Science · doi:10.1126/science.8420006 · Cited by 324
Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models
Steiner, J. P., Hamilton, G. S., Ross, D. T., Valentine, H. L., Guo, H., Connolly, M. A., Liang, S., Ramsey, C., Li, J.-H. J., Huang, W., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2019 · Cited by 324
Nerve growth factor affects11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (Case Report)
Olson, L., Nordberg, A. K., von Holst, H., Bäckman, L., Ebendal, T., Alafuzoff, I. I., Amberla, K., Hartvig, P., Herlitz, A., Lilja, A., et al. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257624 · Cited by 323
Glial Cell Line-Derived Neurotrophic Factor Protects against Ischemia-Induced Injury in the Cerebral Cortex
Wang, Y., Lin, S., Chiou, A. L., Williams, L. R., & Hoffer, B. J. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04341.1997 · Cited by 314
Peptide Drug Delivery to the Brain
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-9-783_2 · Cited by 311
Peptides and the blood-brain barrier: Lipophilicity as a predictor of permeability
Banks, W. A., & Kastin, A. J. (1985) · Brain Research Bulletin · doi:10.1016/0361-9230(85)90153-4 · Cited by 307
Free insulin‐like growth factors (IGF‐I and IGF‐II) in human serum
Frystyk, J., Skjærbæk, C. B., Dinesen, B., & Ørskov, H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00602-4 · Cited by 306
Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases
Mufson, E. J., Kroin, J. S., Sendera, T. J., & Sobreviela, T. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00059-8 · Cited by 296
Keeping track of neurotrophin receptors
Bothwell, M. A. (1991) · Cell · doi:10.1016/0092-8674(91)90540-f · Cited by 292
Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain.
Fung, L. K., Ewend, M. G., Sills, A. K., Sipos, E. P., Thompson, R. C., Watts, M., Colvin, O. M., Brem, H., & Saltzman, W. M. (1998) · PubMed · Cited by 289
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 279
Isoelectric points of proteins: A table
Malamud, D., & Drysdale, J. W. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90790-x · Cited by 266
Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging
Nicholson, C., & Tao, L. (1993) · Biophysical Journal · doi:10.1016/s0006-3495(93)81324-9 · Cited by 266
Insulin-like growth factors and insulin: comparative aspects
Froesch, E. R., & Zapf, J. (1985) · Diabetologia · doi:10.1007/bf00281982 · Cited by 263
A femtomolar-acting neuroprotective peptide.
Brenneman, D. E., & Gozes, I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118672 · Cited by 257
Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection
Morse, J., Wiegand, S., Anderson, K., You, Y., Cai, N., Carnahan, J., Miller, J., DiStefano, P., Altar, C., & Lindsay, R. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04146.1993 · Cited by 251
Lentiviral vectors: regulated gene expression.
Kafri, T., van Praag, H., Gage, F. H., & Verma, I. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0083 · Cited by 251
Cerebrospinal fluid circulation and associated intracranial dynamics. A radiologic investigation using MR imaging and radionuclide cisternography.
Greitz, D. (1993) · PubMed · Cited by 247
Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway
Chen, X., Fawcett, J. R., Rahman, Y., Ala, T. A., & Frey, W. H. (1998) · Journal of Alzheimer s Disease · doi:10.3233/jad-1998-1102 · Cited by 247
Self-citation
Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy
Smith, D. E., Roberts, J. A., Gage, F. H., & Tuszynski, M. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10893 · Cited by 244
Anatomical relationships of the pia mater to cerebral blood vessels in man
Hutchings, M., & Weller, R. O. (1986) · Journal of Neurosurgery · doi:10.3171/jns.1986.65.3.0316 · Cited by 233
Research advances in Alzheimer's disease and related disorders
Iqbal, K., & Disorders, R. (1995) · Wiley eBooks · Cited by 228
Distribution of Intracerebral Ventricularly Administered Neurotrophins in Rat Brain and Its Correlation with Trk Receptor Expression
Yan, Q., Matheson, C. R., Sun, J., Radeke, M. J., Feinstein, S. C., & Miller, J. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1076 · Cited by 217
Distribution of extracellular tracers in perivascular spaces of the rat brain
Ichimura, T., Fraser, P. A., & Cserr, H. F. (1991) · Brain Research · doi:10.1016/0006-8993(91)91275-6 · Cited by 215
Intraputaminal Infusion of Nerve Growth Factor to Support Adrenal Medullary Autografts in Parkinson's Disease
Olson, L. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530160037011 · Cited by 214
Insulin and insulin-like growth factor receptors in the nervous system
Adamo, M. L., Raizada, M. K., & LeRoith, D. (1989) · Molecular Neurobiology · doi:10.1007/bf02935589 · Cited by 212
Delivery of 125 I-NGF to the Brain via the Olfactory Route
Frey, W. H., Liu, J., Chen, X., Thorne, R. G., Fawcett, J. R., Ala, T. A., & Rahman, Y. (1997) · Drug Delivery · doi:10.3109/10717549709051878 · Cited by 210
Self-citation
Neuroprotection with noninvasive neurotrophin delivery to the brain
Wu, D., & Pardridge, W. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.254 · Cited by 209
Transport of molecules from nose to brain: Transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium
Shipley, M. T. (1985) · Brain Research Bulletin · doi:10.1016/0361-9230(85)90129-7 · Cited by 208
TGF-β1 Protects Hippocampal Neurons Against Degeneration Caused by Transient Global Ischemia: Dose-Response Relationship and Potential Neuroprotective Mechanisms
Henrich-Noack, P., Prehn, J. H. M., & Krieglstein, J. (1996) · Stroke · doi:10.1161/01.str.27.9.1609 · Cited by 202
Distribution of nerve growth factor following direct delivery to brain interstitium
Krewson, C. E., Klarman, M. L., & Saltzman, W. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00261-n · Cited by 201
Nasal Route for Direct Delivery of Solutes to the Central Nervous System: Fact or Fiction?
Mathison, S., Nagilla, R., & Kompella, U. B. (1998) · Journal of drug targeting · doi:10.3109/10611869808997870 · Cited by 200
Neural actions of immunophilin ligands
Snyder, S. H., Sabatini, D. M., Lai, M. M.-S., Steiner, J. P., Hamilton, G. S., & Suzdak, P. D. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01146-2 · Cited by 198
Biopharmaceutical benchmarks
Walsh, G. (2000) · Nature Biotechnology · doi:10.1038/78720 · Cited by 198
Intranasal drug delivery
HUSSAIN, A. A. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00060-4 · Cited by 197
Central nervous system effects of intranasally administered insulin during euglycemia in men.
Kern, W., Jan Born, A., Schreiber, H., & Fehm, H. (1999) · Diabetes · doi:10.2337/diabetes.48.3.557 · Cited by 192
Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates
Koliatsos, V. E., Clatterbuck, R. E., Nauta, H. J. W., Knüsel, B., Burton, L. E., Hefti, F. F., Mobley, W. C., & Price, D. L. (1991) · Annals of Neurology · doi:10.1002/ana.410300613 · Cited by 191
Transcytotic pathway for blood-borne protein through the blood-brain barrier.
Broadwell, R. D., Balin, B. J., & Salcman, M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.2.632 · Cited by 186
Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.
Gozes, I., Bardea, A., Reshef, A., Zamostiano, R., Zhukovsky, S., Rubinraut, S., Fridkin, M., & Brenneman, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.427 · Cited by 183
Delayed Treatment with Intravenous Basic Fibroblast Growth Factor Reduces Infarct Size following Permanent Focal Cerebral Ischemia in Rats
Fisher, M., Meadows, M., Do, T., Weise, J., Trubetskoy, V. S., Charette, M., & Finklestein, S. P. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.121 · Cited by 182
Endocytic and exocytic pathways of the neuronal secretory process and trans synaptic transfer of wheat germ agglutinin‐horseradish peroxidase in vivo
Broadwell, R. D., & Balin, B. J. (1985) · The Journal of Comparative Neurology · doi:10.1002/cne.902420410 · Cited by 181
Permeability of the blood–brain barrier to neurotrophins
Pan, W., Banks, W. A., & Kastin, A. J. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01525-4 · Cited by 181
Tracer diffusion of globular proteins in concentrated protein solutions.
Muramatsu, N., & Minton, A. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.2984 · Cited by 178
Growth/Differentiation Factor-15/Macrophage Inhibitory Cytokine-1 Is a Novel Trophic Factor for Midbrain Dopaminergic NeuronsIn Vivo
Strelau, J., Sullivan, A. M., Bottner, M. B., Lingor, P., Falkenstein, E., Suter‐Crazzolara, C., Galter, D., Jászai, J., KRIEGLSTEIN, K. G., & Unsicker, K. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08597.2000 · Cited by 175
Glial Growth Factor 2, a Soluble Neuregulin, Directly Increases Schwann Cell Motility and Indirectly Promotes Neurite Outgrowth
Mahanthappa, N. K., Anton, E. S., & Matthew, W. D. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-15-04673.1996 · Cited by 175
Neuroprotective Gene Therapy for Huntington’s Disease Using a Polymer Encapsulated BHK Cell Line Engineered to Secrete Human CNTF
Bachoud‐Lévi, A., Déglon, N., Nguyen, J., Bloch, J., Bourdet, C., Winkel, L., Rémy, P., Goddard, M. B., Lefaucheur, J. P., Brugières, P., et al. (2000) · Human Gene Therapy · doi:10.1089/10430340050111377 · Cited by 172
The neurotrophins and their receptors
Glass, D. J., & Yancopoulos, G. D. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90054-5 · Cited by 172
Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal
Broadwell, R. D. (1989) · Acta Neuropathologica · doi:10.1007/bf00294368 · Cited by 172
Fibrolast growth factors in the nervous system
Exkenstien, F. P. (1994) · Journal of Neurobiology · doi:10.1002/neu.480251112 · Cited by 167
Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration.
Tuszynski, M. H., Roberts, J. A., Senut, M., U, H. S., & Gage, F. H. (1996) · PubMed · Cited by 164
OVERVIEW OF DRUG‐PROTEIN BINDING
Gillette, J. R. (1973) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1973.tb20464.x · Cited by 161
TGFβ1 and TGFβ2 Concentrations Are Elevated in Parkinson's Disease in Ventricular Cerebrospinal Fluid
Vawter, M. P., Dillon‐Carter, O., Tourtellotte, W. W., Carvey, P. M., & Freed, W. J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0200 · Cited by 158
Activity-Dependent Neurotrophic Factor: Intranasal Administration of Femtomolar-Acting Peptides Improve Performance in a Water Maze
Gozes, I., Giladi, E., Pinhasov, A., Bardea, A., & Brenneman, D. E. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39336-x · Cited by 157
Basic Fibroblast Growth Factor Increases Long-Term Survival of Spinal Motor Neurons and Improves Respiratory Function after Experimental Spinal Cord Injury
Teng, Y. D., Mocchetti, I., Taveira‐DaSilva, A. M., Gillis, R. A., & Wrathall, J. R. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-16-07037.1999 · Cited by 155
Leukemia Inhibitory Factor Augments Neurotrophin Expression and Corticospinal Axon Growth after Adult CNS Injury
Blesch, A., Uy, H. S., Grill, R., Cheng, J.-G., Patterson, P. H., & Tuszynski, M. H. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03556.1999 · Cited by 154
Bioavailability and Transport of Peptides and Peptide Drugs into the Brain
Egleton, R. D., & Davis, T. P. (1997) · Peptides · doi:10.1016/s0196-9781(97)00242-8 · Cited by 151
α2-macroglobulin is a binding protein for basic fibroblast growth factor
Dennis, P. A., Saksela, O., Harpel, P. C., & Rifkin, D. B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83222-7 · Cited by 148
TGF-β in the central nervous system: Potential roles in ischemic injury and neurodegenerative diseases
Pratt, B. M., & McPherson, J. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00018-x · Cited by 148
Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat
Baker, H. A., & Spencer, R. F. (1986) · Experimental Brain Research · doi:10.1007/bf00237470 · Cited by 147
MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF)
Date, I., Notter, M. F. D., Felten, S. Y., & Felten, D. L. (1990) · Brain Research · doi:10.1016/0006-8993(90)90264-c · Cited by 145
Peptides crossing the blood–brain barrier: some unusual observations
Kastin, A. J., Pan, W., Maness, L. M., & Banks, W. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01961-7 · Cited by 144
Identification of a truncated form of the nerve growth factor receptor.
DiStefano, P. S., & Johnson, E. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.1.270 · Cited by 142
Transplants and Neurotrophic Factors Prevent Atrophy of Mature CNS Neurons after Spinal Cord Injury
Bregman, B. S., Broude, E. V., McAtee, M., et al. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6669 · Cited by 141
Prospects for Pharmacological Intervention in Alzheimer Disease
Emilien, G., Beyreuther, K. T., Masters, C. L., & Maloteaux, J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.4.454 · Cited by 140
Cytokines which signal through the LIF receptor and their actions in the nervous system
Murphy, M., Dutton, R., Koblar, S., Cheema, S., & Bartlett, P. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00020-8 · Cited by 138
Neurotrophin‐7: a novel member of the neurotrophin family from the zebrafish
Nilsson, A.-S., Fainzilber, M., Falck, P., & Ibáñez, C. F. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00192-6 · Cited by 136
Drug “Diffusion” within the Braina
Fenstermacher, J. D., & Kaye, T. G. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb31809.x · Cited by 136
The Transport of a Drug to the Cerebrospinal Fluid Directly from the Nasal Cavity: The Relation to the Lipophilicity of the Drug.
Sakane, T., Akizuki, M., Yamashita, S., NADAI, T., Hashida, M., & Sezaki, H. (1991) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.39.2456 · Cited by 135
Patterns of Insulin‐like Growth Factor and IGF Receptor Gene Expression in the Brain: Functional Implications
Bondy, C. A., & LEE, W. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb26203.x · Cited by 135
Alzheimer's disease may begin in the nose and may be caused by aluminosilicates
Roberts, E. (1986) · Neurobiology of Aging · doi:10.1016/0197-4580(86)90119-3 · Cited by 134
Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans
Pietrowsky, R., Strüben, C., Mölle, M., Fehm, H. L., & Jan Born, A. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00180-8 · Cited by 133
Surveillance for morbidity and mortality among older adults--United States, 1995-1996.
Desai, M. M., Zhang, P., & Hennessy, C. H. (1999) · PubMed · Cited by 131
Signaling of the Cardiotrophin-1 Receptor
Robledo, O., Fourcin, M., Chevalier, S., Guillet, C., Auguste, P., Pouplard-Barthelaix, A., Pennica, D., & Gascan, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.4855 · Cited by 126
Recommendations for Nomenclature of the Insulin-Like Growth Factor Binding Protein Superfamily
Baxter, R. C., Binoux, M., Clemmons, D. R., et al. (1998) · Endocrinology · doi:10.1210/endo.139.10.5083 · Cited by 124
Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation
Guo, Q., Sebastian, L., Sopher, B. L., Miller, M. W., Glazner, G. W., Ware, C. B., Martin, G. M., & Mattson, M. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.4125 · Cited by 124
Neurotrophic Factors Enter the Clinic
Barinaga, M. (1994) · Science · doi:10.1126/science.8171331 · Cited by 123
Development of pharmacological agents for targeting neurotrophins and their receptors
Saragovi, H. U., & Gehring, K. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01444-3 · Cited by 121
Characterization of Insulin-Like Growth Factor Binding Proteins Produced in the Rat Central Nervous System*
Ocrant, I., Fay, C. T., & Parmelee, J. T. (1990) · Endocrinology · doi:10.1210/endo-127-3-1260 · Cited by 119
Cellular and Molecular Neurosurgery: Pathways from Concept to Reality-Part II: Vector Systems and Delivery Methodologies for Gene Therapy of the Central Nervous System
Zloković, B. V., & Apuzzo, M. L. J. (1997) · Neurosurgery · doi:10.1097/00006123-199704000-00028 · Cited by 116
Diffusion of albumins in rat cortical slices and relevance to volume transmission
Tao, L., & Nicholson, C. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00303-x · Cited by 116
Entry of pathogens into the central nervous system
TUOMANEN, E. I. (1996) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.1996.tb00245.x · Cited by 112
Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor gp130 dependent pathways
Pennica, D. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00007-x · Cited by 111
Direct Drug Transport from the Rat Nasal Cavity to the Cerebrospinal Fluid: the Relation to the Molecular Weight of Drugs
Sakane, T., Akizuki, M., Taki, Y., Yamashita, S., Sezaki, H., & NADAI, T. (1995) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1995.tb05814.x · Cited by 110
Intrathecal Ciliary Neurotrophic Factor Delivery for Treatment of Amyotrophic Lateral Sclerosis (Phase I Trial)
Penn, R. D., Kroin, J. S., York, M. M., & Cedarbaum, J. M. (1997) · Neurosurgery · doi:10.1097/00006123-199701000-00021 · Cited by 109
Intracranial Delivery of Recombinant Nerve Growth Factor: Release Kinetics and Protein Distribution for Three Delivery Systems
Saltzman, W. M., Mak, M., Mahoney, M. J., Duenas, E. T., & Cleland, J. L. (1999) · Pharmaceutical Research · doi:10.1023/a:1018824324275 · Cited by 106
Nasal swell-bodies and cyclic changes in the air passage of the rat and rabbit nose.
Bojsen-Møller, F., & Fahrenkrug, J. (1971) · PubMed · Cited by 105
Entry of EGF into brain is rapid and saturable
Pan, W., & Kastin, A. J. (1999) · Peptides · doi:10.1016/s0196-9781(99)00094-7 · Cited by 104
Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury
Teng, Y. D., Mocchetti, I., & Wrathall, J. R. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00100.x · Cited by 104
The Blood-brain barrier : cellular and molecular biology
Pardridge, W. M. (1993) · Raven Press eBooks · Cited by 102
Isolation of human nerve growth factor from placental tissue
Goldstein, L., Reynolds, C. P., & Perez-Polo, J. R. (1978) · Neurochemical Research · doi:10.1007/bf00964058 · Cited by 101
Cerebrovascular Accumulation and Increased Blood‐Brain Barrier Permeability to Circulating Alzheimer's Amyloid β Peptide in Aged Squirrel Monkey with Cerebral Amyloid Angiopathy
Mackic, J. B., Weiss, M. H., Miao, W., Kirkman, E., Ghiso, J., Calero, M., Bading, J., Frangione, B., & Zlokovic, B. V. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010210.x · Cited by 101
Receptor‐mediated retrograde transport in CNS neurons after intraventricular administration of NGF and growth factors
Ferguson, I. A., Schweitzer, J. B., Bartlett, P. F., & Johnson, E. M. (1991) · The Journal of Comparative Neurology · doi:10.1002/cne.903130411 · Cited by 100
Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients
Hintzen, R. Q., van Lier, R. A. W., Kuijpers, K. C., et al. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90175-7 · Cited by 100
Neurotrophic factors in the therapy of diabetic neuropathy
Apfel, S. C. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00011-x · Cited by 100
Transfer of Dopamine in the Olfactory Pathway Following Nasal Administration in Mice
Dahlin, M., Bergman, U., Jansson, B., Björk, E., & Brittebo, E. B. (2000) · Pharmaceutical Research · doi:10.1023/a:1007542618378 · Cited by 99
Transport and elimination of recombinant human NGF during long-term delivery to the brain
Krewson, C. E., & Saltzman, W. M. (1996) · Brain Research · doi:10.1016/0006-8993(96)00378-2 · Cited by 99
Altered formation and bulk absorption of cerebrospinal fluid in FGF-2-induced hydrocephalus
Johanson, C. E., Szmydynger‐Chodobska, J., Chodobski, A., et al. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.1.r263 · Cited by 99
Identification of soluble forms of the fibroblast growth factor receptor in blood.
Hanneken, A. M., Ying, W., LING, N. C., & Baird, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9170 · Cited by 94
Hypoxia Dramatically Increases the Nonspecific Transport of Blood‐Borne Proteins to the Brain
Plateel, M., Teissier, E., & Cecchelli, R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020874.x · Cited by 94
Recombinant Human and Rat Ciliary Neurotrophic Factors
Masiakowski, P., Liu, H., Radziejewski, C. H., Lottspeich, F., OBERTHÜR, W., Wong, V., Lindsay, R. M., Furth, M. E., & Panayotatos, N. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08250.x · Cited by 93
Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke
Loddick, S. A., Liu, X.-J., Lu, Z.-X., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1894 · Cited by 91
Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor‐β superfamily, on midbrain dopaminergic neurons
KRIEGLSTEIN, K. G., Suter‐Crazzolara, C., Hötten, G., Pohl, J., & Unsicker, K. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490420516 · Cited by 90
Molecular Mimics of Insulin-like Growth Factor 1 (IGF-1) for Inhibiting IGF-1: IGF-Binding Protein Interactions
Lowman, H. B., Chen, Y. M., Skelton, N. J., Mortensen, D. L., Tomlinson, E. E., Sadick, M. D., Robinson, I. C. A. F., & CLARK, R. G. (1998) · Biochemistry · doi:10.1021/bi980426e · Cited by 89
Engineering Targeted In Vivo Drug Delivery. I. The Physiological and Physicochemical Principles Governing Opportunities and Limitations
Hunt, C. A., MacGregor, R. D., & Siegel, R. A. (1986) · Pharmaceutical Research · doi:10.1023/a:1016332023234 · Cited by 88
Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging
Martı́nez-Serrano, A., & Björklund, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1858 · Cited by 87
The nasal route of cerebrospinal fluid drainage in man. A light–microscope study
Löwhagen, P. H., Johansson, B. B., & Nordborg, C. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb01008.x · Cited by 86
A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin
Pietrowsky, R., Thiemann, A., Kern, W., Fehm, H. L., & Jan Born, A. (1996) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(96)00012-1 · Cited by 86
Involvement of amyloid precursor protein in functional synapse formation in cultured hippocampal neurons
Morimoto, T., Ohsawa, I., Takamura, C., Ishiguro, M., & Kohsaka, S. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980115)51:2 · Cited by 85
Effect of endotoxin on permeability of bovine cerebral endothelial cell layers in vitro.
de Vries, H. E., Blom-Roosemalen, M. C. M., Boer, A. G. D., van Berkel, T. J. C., Breimer, D. D., & Kuiper, J. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13090-5 · Cited by 84
Expression of polypeptide variants of receptor-type protein tyrosine phosphatase ?: The secreted form, phosphacan, increases dramatically during embryonic development and modulates glial cell behavior in vitro
Sakurai, T., Friedlander, D. R., & Grumet, M. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960315)43:6 · Cited by 84
Cholinesterase Inhibitor Therapy Stabilizes Symptoms of Alzheimer Disease
Giacobini, E. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00002 · Cited by 84
Role of Insulin‐like Growth Factor Binding Proteins in Modifying IGF Actionsa
Clemmons, D. R., Jones, J. I., Busby, W. H., & Wright, G. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb26201.x · Cited by 83
Pharmacokinetics of Intrathecally Applied BDNF and Effects on Spinal Motoneurons
Dittrich, F., Ochs, G., Große-Wilde, A., Berweiler, U., Yan, Q., Miller, J. A., Toyka, K. V., & Sendtner, M. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0157 · Cited by 83
Mechanism of platelet-derived growth factor (PDGF) AA, AB, and BB binding to alpha and beta PDGF receptor.
Fretto, L. J., Snape, A. J., Tomlinson, J. E., et al. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53739-x · Cited by 82
Experimental Therapeutics of Neurodegenerative Disorders: Unmet Needs
Shoulson, I. (1998) · Science · doi:10.1126/science.282.5391.1072 · Cited by 82
Structural Determinants of Neurotrophin Action
McDonald, N. Q., & Chao, M. V. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19669 · Cited by 82
Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the dissociation of the drug
Sakane, T., Akizuki, M., Yamashita, S., Sezaki, H., & NADAI, T. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03817.x · Cited by 79
Sleep and endocrine changes after intranasal administration of growth hormone-releasing hormone in young and aged humans
Perras, B., Marshall, L., Köhler, G., Jan Born, A., & Fehm, H. L. (1999) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00027-x · Cited by 78
Glutaraldehyde fixation increases retention of low molecular weight proteins (growth factors) transferred to nylon membranes for Western blot analysis
Karey, K. P., & Sirbasku, D. A. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90634-9 · Cited by 78
Effect of transient focal ischemia on blood-brain barrier permeability in the rat: correlation to cell injury
Albayrak, S., Zhao, Q., Siesjö, B. K., et al. (1997) · Acta Neuropathologica · doi:10.1007/s004010050688 · Cited by 77
Immunophilin Ligands and GDNF Enhance Neurite Branching or Elongation from Developing Dopamine Neurons in Culture
Costantini, L. C., & Ole Isacson, A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7417 · Cited by 77
Intrathecal Drug Administration
Kroin, J. S. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199222050-00001 · Cited by 76

Research works printed but not linked: 15

Walsh, 1995, Biol Technol, 13, 1167
Desai, 1999, Mor Mortal Wkly Rep CDC Surveill Summ, 48, 7
Foldi, 1996, Lymphology, 29, 1
Kuo, 1991, J Chromatogr B Biomed Sci Appl, 543, 463
Tanaka, 1997, Res Commun Mol Pathol Pharmacol, 96, 267
Frystyk, 1995, Am J Physiol, 269, E840
Fung, 1998, Cancer Res, 58, 672
Penn, 1997, Neurosurgery, 40, 94
Apfel, 1996, Ciba Found Symp, 196, 98
de Vries, 1996, J Pharmacol Exp Ther, 277, 1418
Venero, 1996, Mol Pharmacol, 49, 303
DeSesso, 1993, Qual Assur, 2, 213
Bojsen-Moller, 1971, J Anat, 110, 25
Kaechi, 1993, J Pharmacol Exp Ther, 264, 321
Tuszynski, 1996, Gene Ther, 3, 305

Sorted by citations

Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Self-citation
Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Self-citation
GDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration
Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.004 · Cited by 820
Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
The blood-brain barrier: structure, function and therapeutic approaches to cross it.
Tajes, M., Ramos-Fernández, E., Weng-Jiang, X., Bosch-Morató, M., Guivernau, B., Eraso-Pichot, A., Salvador, B., Fernàndez-Busquets, X., Roquer, J., & Muñoz, F. J. (2014) · Molecular Membrane Biology · doi:10.3109/09687688.2014.937468 · Cited by 380

See all 487

Authors: Thorne, R. G., & Frey, W. H.
Affiliations: Regions Hospital (US)
ORCID: Thorne, Robert G.
Frey, William H.
Venue: Clinical Pharmacokinetics
Publisher: Springer Science and Business Media LLC
Published: 2001
Volume: 40
Issue: 12
Pages: 907-946
ISSN: 0312-5963 (ISSN-L)
DOI: 10.2165/00003088-200140120-00003
OpenAlex: W1973304468
Cited by: 487
References: 310
Citations by year: 2026: 10 · 2025: 15 · 2024: 19 · 2023: 20 · 2022: 21 · 2021: 24 · 2020: 31 · 2019: 17 · 2018: 24 · 2017: 17 · 2016: 26 · 2015: 26 · 2014: 26 · 2013: 28 · 2012: 20
FWCI: 1.14
Type: journal article
Language: en
Open access: closed
Locations: Clinical Pharmacokinetics (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords: neurotrophic factors, brain drug delivery, blood-brain barrier, blood-CSF barrier, intrathecal administration, intracerebroventricular administration, intranasal drug delivery, intraparenchymal injection, gene therapy, small molecule mimetics, central nervous system disorders, traumatic brain injury, pharmacokinetics, immunogenicity
MeSH terms: Animals, Central Nervous System Diseases, Drug Combinations, Humans, Nerve Growth Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks